CC
HSCS icon

Cultivar Capital’s Heart Test Laboratories HSCS Stock Holding History

Cultivar Capital’s Portfolio HSCS Stock Details HSCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-500
Closed -$2.6K – 101
2024
Q2 		$2.6K Hold
500
– – ﹤0.01% 176
2024
Q1 		$5.84K Hold
500
– – 0.01% 31
2023
Q4 		$8.55K Buy
+500
New +$12.3K 0.01% 30

Other funds holding HSCS

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OLVIG
Oliver Lagore Vanvalin Investment Group Flint, Michigan $255M AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cultivar Capital's HSCS Position: Q3 2024 in Review

Cultivar Capital sold out of Heart Test Laboratories (HSCS) in Q3 2024, closing a stake of 500 shares — an estimated $2.6K sold.

Cultivar Capital first reported a position in HSCS in Q4 2023 and held it in 3 quarters. The position peaked at $8.55K in Q4 2023. 6 funds tracked by Wall St. Rank hold HSCS as of Q3 2024.

  • Cultivar Capital reported no remaining Heart Test Laboratories position as of Q3 2024 after selling out during the quarter.
  • Cultivar Capital sold 500 Heart Test Laboratories shares in Q3 2024, an estimated $2.6K.
  • Cultivar Capital first reported a position in Heart Test Laboratories in Q4 2023 and held it in 3 quarters.
  • Cultivar Capital's Heart Test Laboratories position peaked at $8.55K in Q4 2023.
  • 6 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q3 2024.

Based on Cultivar Capital's 13F filing for Q3 2024, filed 16 Oct 2024.